St Bartholomew's Hospital, commonly known as Barts, is a teaching hospital located in the City of London. It was founded in 1123 and is currently run by Barts Health NHS Trust.

There are 387 beds in St. Bartholomew'S Hospital; Dept of Medical Oncology.

During the past decade, St. Bartholomew'S Hospital; Dept of Medical Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Bartholomew'S Hospital; Dept of Medical Oncology" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Agennix" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Celgene Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Bartholomew'S Hospital; Dept of Medical Oncology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "St. Bartholomew'S Hospital; Dept of Medical Oncology" are "Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Hormone Refractory Prostate Cancer" (1 trials), "Kidney Neoplasms" (1 trials) and "Lymphoma, Non-Hodgkin" (1 trials). Many other conditions were trialed in "St. Bartholomew'S Hospital; Dept of Medical Oncology" in a lesser frequency.

Most popular intervention types in "St. Bartholomew'S Hospital; Dept of Medical Oncology" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Bartholomew'S Hospital; Dept of Medical Oncology" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "St. Bartholomew'S Hospital; Dept of Medical Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in St. Bartholomew'S Hospital; Dept of Medical Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Bartholomew'S Hospital; Dept of Medical Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".